UK launch for Cardiome’s skin infections antibiotic
A one- or two-shot antibiotic has been launched in the UK for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.
Read More
Tag: Cardiome
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
